UPDATE 1-FDA approves Bristol-Myers' immunotherapy for skin cancer
December 22, 2014 at 15:31 PM EST
Dec 22 (Reuters) - The U.S. Food and Drug Administration approved Bristol-Myers Squibb Co's skin cancer drug, more than three months before the scheduled review date.
